bioRxiv / medRxivopen access
Safety and immunogenicity of recombinant hepatitis E vaccine in healthy pregnant women between 14 and 34 weeks of gestation and non-pregnant women of reproductive age: Protocol for a Phase II, randomized, observer-blinded, placebo-controlled trial
public and global health
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 660955
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.